Tocagen Inc. today announced the publication of data showing the company’s investigational treatment for high grade glioma eradicates brain tumors and provides a dramatic survival benefit in mouse models of glioblastoma.
No Comments »
Filed under: Pharmacy News
An experimental drug, clazosentan, reduced the risk of blood vessel spasm in patients with a brain aneurysm, according to research presented at the American Stroke Association’s International Stroke Conference 2012.
No Comments »
Filed under: Pharmacy News
Researchers at Oregon Health & Science University have discovered that a molecule critical to the development and plasticity of nerve cells - brain-derived neurotrophic factor (BDNF) - is severely lacking in brainstem neurons in mutations leading to Rett syndrome, a neurological developmental disorder…
No Comments »
Filed under: Women's Health
Today, the U.S. Food and Drug Administration allowed marketing of the first test to help determine the risk for a rare brain infection called progressive multifocal leukoencephalopathy (PML) in people using the drug Tysabri (natalizumab) to treat multiple sclerosis (MS) or Crohn’s disease.
No Comments »
Filed under: Pharmacy News
Anabolic steroids don’t appear to contribute to degenerative brain disease caused by repeated head trauma in athletes, according to a study in the January issue of Neurosurgery, official journal of the Congress of Neurological Surgeons.
No Comments »
Filed under: Pharmacy News
(MedPage Today) — Two new cases of a life-threatening brain inflammation have been seen in patients treated with the lymphoma drug brentuximab vedotin (Adcetris), the FDA said.
No Comments »
Filed under: Pharmacy News
Brain cancer cells are particularly resistant to chemotherapy - toxins enter the cells, but before the toxins can kill, cancer cells quickly pump them back outside. In fact, brain cancer cells are even better than healthy cells at cleaning themselves. This means that when hit with chemotherapy, healthy cells tend to die before brain cancer [...]
No Comments »
Filed under: Pharmacy News
The main psychoactive components of marijuana, THC and cannabidiol, have opposite effects on brain function. The first can induce psychosis, the second can have antipsychotic properties. Medscape Medical News
No Comments »
Filed under: General Health News
A national clinical trial testing the efficacy of a novel brain tumor vaccine has begun at Wake Forest Baptist Medical Center, the only facility in the Southeast to participate.
No Comments »
Filed under: Pharmacy News
Different ingredients in marijuana appear to affect regions of the brain differently during brain processing functions involving responses to certain visual stimuli and tasks, according to a report in the January issue of Archives of General Psychiatry, one of the JAMA/Archives journals.
No Comments »
Filed under: Pharmacy News
